BridgeMD
New treatment option for Mechanical Ventilation
Official title Dead Space in Mechanical Ventilation With Constant Expiratory Flow
ClinicalTrials.gov ID: NCT06024993
What this study is testing
- What it's testing
- Conventional continuous mandatory mechanical ventilation relies on the passive recoil of the chest wall for expiration. This results in an exponentially decreasing expiratory flow.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Adults [18-70] yrs
- General anaesthesia for elective surgery
- Arterial line, central venous line and endotracheal tube as part of standard of care
- Expected duration of controlled mechanical ventilation ≥ 60 minutes
- Supine position (0±10°)
You likely can't join if
- One lung ventilation
- Known pregnancy
- Increased intra-abdominal pressure (pneumoperitoneum or obesity (BMI \> 30kg/m2))
- COPD GOLD IV or home oxygen dependence
- Cardiac pacemaker, implantable cardioverter-defibrillator (ICD) or thoracic neurostimulator
- Skin lesions (e.g. injury, inflammation) at the level where the Electrical Impedance Tomography (EIT) band is to be applied
See the full eligibility criteria
- Adults [18-70] yrs
- General anaesthesia for elective surgery
- Arterial line, central venous line and endotracheal tube as part of standard of care
- Expected duration of controlled mechanical ventilation ≥ 60 minutes
- Supine position (0±10°)
- One lung ventilation
- Known pregnancy
- Increased intra-abdominal pressure (pneumoperitoneum or obesity (BMI \> 30kg/m2))
- COPD GOLD IV or home oxygen dependence
- Cardiac pacemaker, implantable cardioverter-defibrillator (ICD) or thoracic neurostimulator
- Skin lesions (e.g. injury, inflammation) at the level where the Electrical Impedance Tomography (EIT) band is to be applied
- Clinical signs of raised intracranial pressure
- Potential interference with the surgery due to the setup of the study instruments.
- Patient refusal to participate
The study team makes the final eligibility decision.
Where it's taking place
- Edegem, Antwerp, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edegem, Antwerp, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.